RNA Analytical/Quality Videos
-
Regulatory And Biosafety Testing Expertise
3/31/2026
Advancing biologics requires confidence in safety, quality, and compliance. Learn how integrated analytical and biosafety testing, backed by decades of expertise, helps reduce risk.
-
Your Roadmap For Efficient Processes
3/4/2025
Struggling with mRNA integrity? Discover essential strategies to boost stability in mRNA manufacturing with innovative endonuclease-free DTT and Spermidine chemicals.
-
Robust And Cost-Effective mRNA Capping
12/8/2025
Master the essential strategies for cost-effective and robust mRNA capping at industrial scale. Learn how to successfully evaluate new materials and optimize your synthesis process for maximum efficiency and yield.
-
What Does 2025 (And Beyond) Hold For The RNA-LNP Space?
12/4/2024
Three LNP experts share their thoughts on the incremental advancements they’d like to see the RNA-LNP space make in the next few years.
-
The State Of CircRNA Analytical Development
8/22/2024
Advancing RNA LIVE panelist Jim Nolan of Sail Biomedicines fills us in on the extent to which we can rely on the linear mRNA analytical foundations established today.
-
How "Successful" Are Our mRNA-LNP Outsourcing Partnerships Today?
2/10/2025
In this snippet, panelist Alex Aust (with the help of several live attendee commenters) tackles a particularly tricky question: Are our outsourcing partnerships producing high quality products today, and what are the most common root causes of batch failures?
-
Streamline Your mRNA Purification Steps
3/4/2025
Ensure your mRNA's stability and effectiveness post-transcription with advanced filtration and chromatography techniques to enhance purity and recovery, which delivers high-quality mRNA for superior therapeutics and vaccines.
-
The Evolutions Of mRNA Analytical Development (So Far)
8/22/2024
Linear mRNA analytical development has been rapidly advancing in the past few years and this panel discussion explores some of the biggest changes we’ve seen in the linear mRNA analytical paradigm.
-
Engaging Early In Process Development To Bring mRNA Sequences To Life
Examine why template sequence characteristics are relevant for cGMP manufacturing of high-quality mRNA and consider insights on how to develop a scalable, robust, and economically viable process.
-
Closing the Gap: How NIST is Addressing gRNA Quality
4/29/2026
Life Edit Therapeutics’ April Sena provides an update on NIST’s gene editing consortium, teasing forthcoming deliverables from a working group focused on gRNA quality.